Items of note,
Looking closely at history,
Very similarly to 2016, the 2014 run shows a peak of about .46 then a quick pullback to .20 then within a few weeks it legged up to .80 and so forth from there.
So the .42 to .22 is a viable metaphor here. RSI early peak also basically identical.
Clearly from a branding , marketing, logic, and buzz optimization standpoint, and I know this is a topic oft discussed here, the merger now complete, the ticker should be BLUM. Not ivxx. It is the name on the stores, much more known about town and has brand cache. In fact today they should in my view push forward as Blum, but that is up to the BOD.
Meanwhile this chatter of the recent purchase of the neutraceutical co for 1.25mm is interesting and obviously straytegic .
Noone has got it correct in my view.
The payment is a conv promissory note bearing 1% due in 365 days with kickers for elevated revenues generated by these assets above 1.6mm and also above 3.0mm area. So the deal contemplates to cash outlay from trtc, really no interest, convertible based on price of stock 365 days from now, not current SPX, and asset may generate sales 200+ % of cost to trtc.
So obviously trtc believes there is something special here and is keeping it under wraps for now.
So the question is how does this purchase tie in with trtc s biz?
Is it a drink or pill platform?
Who knows....
And the beat goes on.